Virios Therapeutics Inc

-0.42 (-8.59%)
Earnings Announcements

Virios Therapeutics Announces Q4, FY 2021 Financial Results

Published: 03/17/2022 11:25 GMT
Virios Therapeutics Inc (VIRI) - Virios Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update.
Q4 Loss per Share $0.54.
Cash on Hand of $14.0 Million on December 31, 2021, Provides Runway Through Q1 2023.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.51

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.52

More details on our Analysts Page.